E-ISSN 2347-6923 | ISSN 2277-4092
 

Original Research 


Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial

Raj Kumar, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, Amit Singh.

Abstract
Background: The burden of present pandemic of COVID-19 is increasing exponentially day by day. There is a felt need for
research on various treatment options available in the indigenous system of medicine. Ayurvedic (Indian system of medicine)
preparations have been proven previously to be effective in many viral illnesses and play an important role in boosting the
immunity of the human body.
Aim and Objectives: To evaluate the therapeutic response of ayurvedic preparation RNB on severe COVID-19 patients.
Methodology: A double-blind randomized placebo controlled clinical trial was conducted on 49 severely ill patients of COVID- 19 with one arm receiving RNB and the other placebo. Patients were evaluated on day-to-day basis and clinical improvement was assessed by a two-point reduction in patients’ admission status on a six-point ordinal scale.
Results: Statistically significant (p=0.003) difference in proportion of conversion of Real Time Polymerase Chain Reaction (RT-PCR) result after six days of intervention was observed in both groups. The mean ± SD days required for the patients to become negative by RT-PCR test was shorter in RNB compared (10.1 ± 4.1 days) versus 14.4 ± 5.9 days in control group of patients and was found to be statistically significant (p=0.012). Average days to achieve two-point improvement on “sixpoint
clinical improvement ordinal scale” was shorter in RNB group in comparison to placebo control group (7.9 ± 4.1 days versus 11.7 ± 4.7, p=0.009). The duration of hospital-stay and oxygen therapy required for management of COVID-19 cases was shorter in RNB intervention patients than in control group.
Conclusion: Immunomodulatory, anti-inflammatory, anti-viral and broncho-dilatory properties in ayurvedic formulation makes RNB an ideal drug to act as an adjuvant to standard allopathic treatment against COVID-19 illness even in severely and critically ill patients in the present scenario.

Key words: COVID-19, Ayurvedic medicine, SARS-CoV-2, RT-PCR


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Raj Kumar
Articles by Ramakant Yadav
Articles by Usha Shukla
Articles by Naresh Pal Singh
Articles by Sushil Kumar Yadav
Articles by Sushil Kumar Shukla
Articles by Manoj Kumar
Articles by Amit Singh
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM. 2021; 10(3): 231-243. doi:10.5455/AAM.88853


Web Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. https://www.aamjournal.in/?mno=88853 [Access: December 05, 2023]. doi:10.5455/AAM.88853


AMA (American Medical Association) Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM. 2021; 10(3): 231-243. doi:10.5455/AAM.88853



Vancouver/ICMJE Style

Kumar R, Yadav R, Shukla U, Singh NP, Yadav SK, Shukla SK, Kumar M, Singh A. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM. (2021), [cited December 05, 2023]; 10(3): 231-243. doi:10.5455/AAM.88853



Harvard Style

Kumar, R., Yadav, . R., Shukla, . U., Singh, . N. P., Yadav, . S. K., Shukla, . S. K., Kumar, . M. & Singh, . A. (2021) Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. AAM, 10 (3), 231-243. doi:10.5455/AAM.88853



Turabian Style

Kumar, Raj, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, and Amit Singh. 2021. Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. Annals of Ayurvedic Medicine, 10 (3), 231-243. doi:10.5455/AAM.88853



Chicago Style

Kumar, Raj, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, and Amit Singh. "Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial." Annals of Ayurvedic Medicine 10 (2021), 231-243. doi:10.5455/AAM.88853



MLA (The Modern Language Association) Style

Kumar, Raj, Ramakant Yadav, Usha Shukla, Naresh Pal Singh, Sushil Kumar Yadav, Sushil Kumar Shukla, Manoj Kumar, and Amit Singh. "Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial." Annals of Ayurvedic Medicine 10.3 (2021), 231-243. Print. doi:10.5455/AAM.88853



APA (American Psychological Association) Style

Kumar, R., Yadav, . R., Shukla, . U., Singh, . N. P., Yadav, . S. K., Shukla, . S. K., Kumar, . M. & Singh, . A. (2021) Therapeutic Response of Ayurvedic Preparation Raj Nirwan Bati on Severe COVID-19 Patients: A Double-Blind Randomized Placebo Controlled Clinical Trial. Annals of Ayurvedic Medicine, 10 (3), 231-243. doi:10.5455/AAM.88853